Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

DOP13: Effect of 8 weeks of combined aerobic and resistance exercise on quality of life, muscle strength, aerobic capacity, and disease activity in patients with Inflammatory Bowel Disease; a parallel group randomized clinical trialECCO'24 Stockholm
Year: 2024
Authors: Alborzi Avanaki, Foroogh
DOP14: Proctocolectomy is associated with improved transplant-free survival in patients with primary sclerosing cholangitis: results from a pooled collaborative international studyECCO'24 Stockholm
Year: 2024
Authors: Mol, Bregje
DOP15: Results of a pragmatic multicentred randomised controlled trial investigating the use of personalised golimumab dosing in Ulcerative Colitis: the GOAL-ARC study (GLM dose Optimisation to Adequate Levels to Achieve Response in Colitis)ECCO'24 Stockholm
Year: 2024
Authors: Doherty, Glen
DOP16: Safety of long-term ozanimod treatment for up to 4 years in patients with moderately to severely active Ulcerative Colitis: an interim analysis of the True North open-label extensionECCO'24 Stockholm
Year: 2024
Authors: D'Haens, Geert
DOP17: Tofacitinib versus Vedolizumab Among Bio-naïve Patients With Ulcerative Colitis: A Real-World Propensity-Weighted ComparisonECCO'24 Stockholm
Year: 2024
Authors: Gros, Beatriz
DOP18: Efficacy of risankizumab versus ustekinumab by baseline Crohn’s Disease location: post-hoc analysis of the SEQUENCE head-to-head trialECCO'24 Stockholm
Year: 2024
Authors: Peyrin-Biroulet, Laurent
DOP19: High dimensional profiling of IL-23-responsive cells revealed molecular signatures that predict response to anti-IL-23 therapy in patients with Crohn’s DiseaseECCO'24 Stockholm
Year: 2024
Authors: Deepak, Parakkal
DOP20: Changes in systemic antibody epitope repertoires from preclinical to established Inflammatory Bowel DiseaseECCO'24 Stockholm
Year: 2024
Authors: Bourgonje, Arno R.
DOP21: Histo-endoscopic remission (HEMR) Predicts Future Relapse in Patients with Ulcerative Colitis and is Associated with Lower Colectomy RiskECCO'24 Stockholm
Year: 2024
Authors: Lenfant, Matthias
DOP22: Predictive biomarkers of therapeutic response in Inflammatory Bowel Disease: a step towards personalized medicine.ECCO'24 Stockholm
Year: 2024
Authors: Baldan-Martin, Montserrat
DOP23: The role of histology for the prediction of clinical relapse in Crohn’s Disease: A substudy of the STORI cohortECCO'24 Stockholm
Year: 2024
Authors: Reenaers, Catherine
DOP24: Multi-omic sequencing reveals distinctive gene expression and DNA methylation alterations as potential predictors of primary sclerosing cholangitis development in treatment-naïve paediatric Ulcerative ColitisECCO'24 Stockholm
Year: 2024
Authors: Rodriguez Sosa, Alejandra
DOP25: Antibodies against Neutrophil Extracellular Traps (ANETAs) are associated with more severe disease course in Ulcerative ColitisECCO'24 Stockholm
Year: 2024
Authors: Mendieta Escalante, Erick Arturo
DOP26: Metagenomic and metabolomic profiles in IBD: understanding microbial and metabolic shifts from a large deeply phenotyped cohortECCO'24 Stockholm
Year: 2024
Authors: Sokol, Harry
DOP27: Systemic antibody responses against gut microbiota flagellins implicate shared and divergent immune reactivity in Crohn's Disease and chronic fatigue syndromeECCO'24 Stockholm
Year: 2024
Authors: Bourgonje, Arno R.
DOP28: Yield of surveillance colonoscopy in patients with Primary Sclerosing CholangitisECCO'24 Stockholm
Year: 2024
Authors: Van De Pol, Natasja
DOP29: Capsule endoscopy-guided proactive treatment versus standard treatment of patients with quiescent Crohn’s Disease: The CURE-CD randomized controlled trialECCO'24 Stockholm
Year: 2024
Authors: Ben-Horin, Shomron
DOP30: Cross-ethnic microbiome analyses identify shared and specific signals for Northern Indian IBD patientsECCO'24 Stockholm
Year: 2024
Authors: Gacesa, Ranko
DOP31: Gene correlation network analyses reveal transcript modules and pathogenic mechanisms associated with resistance and response to ustekinumab therapy in Ulcerative ColitisECCO'24 Stockholm
Year: 2024
Authors: Saifuddin, Aamir
DOP32: CD226+TIGITneg expression identifies pathogenic inflammatory CD4+ memory T cells in severe Crohn’s Disease patients, opening up opportunities for patient-tailored treatment strategies.ECCO'24 Stockholm
Year: 2024
Authors: Barendregt, Danielle